Identification of second malignancies on effusions and fine-needle aspirates using a panel of monoclonal antibodies
1997

Identifying Second Malignancies Using Monoclonal Antibodies

Sample size: 334 publication Evidence: high

Author Information

Author(s): M Mottolese, I Venturo, M Rinaldi, M Lopez, G Bigotti, M Benevolo, PG Natali

Primary Institution: Regina Elena Cancer Institute

Hypothesis

Can selected combinations of monoclonal antibodies increase the accuracy of detecting second primary tumors in cytological specimens?

Conclusion

The use of monoclonal antibodies significantly improves the identification of second primary tumors compared to conventional cytology.

Supporting Evidence

  • Immunocytochemical analysis of 334 specimens showed improved accuracy in identifying second primary tumors.
  • 199 out of 243 effusions were identified as metastatic from the first tumor.
  • 44 second primary tumors were identified with 84% correlation to clinical and pathological findings.

Takeaway

Doctors can use special antibodies to find new cancers in patients who have already had cancer, making it easier to spot these new tumors.

Methodology

The study analyzed 334 cytological specimens using immunocytochemical analysis with a panel of monoclonal antibodies.

Limitations

Some cases could not be diagnosed beyond general terms like 'adenocarcinoma' until histological examination was available.

Participant Demographics

Patients with a past history of malignancy, including various types of cancers.

Statistical Information

P-Value

p<0.0001

Statistical Significance

p<0.0001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication